Direct reprogramming: Bypassing stem cells for therapeutics

JAMA - Journal of the American Medical Association

Volumn 314, Issue 1, 2015, Pages 19-20

  Marbán, Eduardo ^a   Cingolani, Eugenio ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD1 PROTEIN; NEUROGENIN 3; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ATOH1; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR MEF2C; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR TBX18; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG;

ARTICLE; ATOH1 GENE; BLASTOCYST; CELL DIFFERENTIATION; CELL LOSS; CELL MIGRATION; CELL REGENERATION; EMBRYONIC STEM CELL; FETUS GROWTH; FIBROBLAST; GATA4 GENE; HEARING IMPAIRMENT; HEART BLOCK; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAFA GENE; MEF2C GENE; MYOD1 GENE; NERVE CELL; NEUROG3 GENE; NONHUMAN; NUCLEAR REPROGRAMMING; PANCREAS CELL; PANCREAS ISLET BETA CELL; PDX1 GENE; PHASE 1 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SICK SINUS SYNDROME; STEM CELL; STEM CELL TRANSPLANTATION; TBX18 GENE; TBX5 GENE; PROCEDURES; THERAPY;

CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS; THERAPEUTICS;

EID: 84937232378     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.4504     Document Type: Article

References (9)

1. Yamanaka S. Nobel lecture: a winding road to pluripotency [video]. http://www.nobelprize.org/mediaplayer/index.php?id=1866. Accessed June 4, 2015.
2. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987;51(6):987-1000.
3. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA. In vivo reprogramming of adult pancreatic exocrine cells to beta cells. Nature. 2008;455(7213):627-632.
4. Qian L, Huang Y, Spencer CI, et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature. 2012;485(7400):593-598.
5. Hu YF, Dawkins JF, Cho HC, Marbán E, Cingolani E. Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block. Sci Transl Med. 2014;6(245):245ra94.
6. Izumikawa M, Minoda R, Kawamoto K, et al. Auditory hair cell replacement and hearing improvement by ATOH1 gene therapy in deaf mammals. Nat Med. 2005;11(3):271-276.
7. Atkinson PJ, Wise AK, Flynn BO, Nayagam BA, Richardson RT. Hair cell regeneration after ATOH1 gene therapy in the cochlea of profoundly deaf adult guinea pigs. PLoS One. 2014;9(7):e102077.
8. Clinicaltrials.gov. Safety, tolerability, and efficacy for CGF166 in patients with bilateral severe-to-profound hearing loss. https://www.clinicaltrials.gov/ct2/show/NCT02132130?term=NCT02132130&rank=1. Accessed June 5, 2015.
9. Doudna JA. Genomic engineering and the future of medicine.JAMA. 2015;313(8):791-792.